Skip to main content

Table 1 Demographic and clinicopathological characteristics of 2102 rectal cancer patients

From: Determining the survival benefit of postoperative radiotherapy in patients with pT1-3N1M0 rectal cancer undergoing total mesorectal excision: a retrospective analysis

Variables

No-radio (n = 718)

Radio (n = 1384)

P value

Gender

  

0.094

 Male

386 (53.8%)

797 (57.6%)

 

 Female

332 (46.2%)

587 (42.4%)

 

Age, Y

  

0.757

  ≤ 60

384 (53.5%)

750 (54.2%)

 

  > 60

334 (46.5%)

634 (45.8%)

 

Year of diagnosis

  

0.000

 2004–2009

303 (42.2%)

794 (57.4%)

 

 2010–2016

415 (57.8%)

590 (42.6%)

 

Race

   

 White

583 (81.2%)

1117 (80.7%)

0.451

 Black

56 (7.8%)

121 (8.7%)

 

 Other

79 (11.0%)

146 (10.5%)

 

Grade

  

0.200

 Grade I/II

592 (82.5%)

1125 (81.3%)

 

 Grade III/IV

112 (15.6%)

213 (15.4%)

 

 Unknown

14 (1.9%)

46 (3.3%)

 

Histology

  

0.846

 Adenocarcinoma

672 (93.6%)

1295 (93.6%)

 

 Mucinous & SRCC*

40 (5.6%)

74 (5.3%)

 

 Others

6 (0.8%)

15 (1.1%)

 

Tumor size (mm)

  

0.929

  ≤ 50

510 (71.0%)

989 (71.5%)

 

  > 50

149 (20.8%)

278 (20.1%)

 

 Unknown

59 (8.2%)

117 (8.5%)

 

Surgical type

   

 Sphincter preservation

640 (89.1%)

1154 (83.4%)

0.000

 APR

78 (10.9%)

230 (16.6%)

 

T stage

  

0.151

 T1

127 (17.7%)

200 (14.5%)

 

 T2

175 (24.4%)

349 (25.2%)

 

 T3

416 (57.9%)

835 (60.3%)

 

Number of nodes resected

  

0.000

  < 12

147 (20.5%)

388 (28.0%)

 

  ≥ 12

571 (79.5%)

996 (72.0%)

 

Number of nodes positive

  

0.147

 1

382 (53.2%)

675 (48.8%)

 

 2

210 (29.2%)

451 (32.6%)

 

 3

126 (17.5%)

258 (18.6%)

 
  1. *SRCC Signet ring cell carcinoma